Lavie Bio
Microbiome-based Products for Improved Food Quality
Company Overview
Snapshot
Founded in January 2019, Lavie Bio operates with 11–50 employees and has raised a total of $37M across three funding rounds from two investors. The company was acquired by ICL in April 2025.
Business overview
Lavie Bio is an Agriculture & Food Technologies company focused on enhancing food quality, health, and agricultural sustainability through microbiome-based agricultural biological products. The company develops biostimulants and biopesticides using proprietary computational predictive technologies, with a specific focus on corn biostimulants through an ongoing collaboration with Corteva. Lavie Bio operates within the Ag Tech sector, serving the agriculture and food industries, particularly in crop treatment and genetics.
Strategic signal
In September 2024, Lavie Bio received a grant from the Israel Innovation Authority to advance its 'MicroFermentor' technology. This grant signals validation for Lavie Bio's innovative approach to making ag-biologicals more economically viable, which could significantly impact the sustainable farming and agricultural input markets by enabling broader adoption of microbiome-based solutions.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent development for Lavie Bio?
- In April 2025, Lavie Bio was acquired by ICL, marking a significant milestone for the company.
- What strategic partnership did Lavie Bio announce in February 2024?
- In February 2024, Lavie Bio and Syngenta announced a partnership to discover and develop novel bio-insecticides.
- What grant did Lavie Bio receive in September 2024?
- In September 2024, Lavie Bio received a grant from the Israel Innovation Authority to advance the development of its 'MicroFermentor' technology.
- What licensing agreement did Lavie Bio secure in July 2023?
- In July 2023, Lavie Bio announced a licensing agreement for bio-fungicides with Corteva Agriscience.
- What strategic collaboration did Lavie Bio enter into with ICL in August 2022?
- In August 2022, Lavie Bio and ICL entered into a strategic collaboration to develop novel bio-stimulant products, with ICL Planet Startup Hub investing in the company.